Pulmonary Artery Hypertension Clinical Trial
Official title:
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension: a Randomized Control Study
NCT number | NCT04337671 |
Other study ID # | 2019HAHA |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2, 2018 |
Est. completion date | December 28, 2019 |
Verified date | April 2020 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study investigated the effect of 12 weeks of aerobic training on sleep quality and aerobic fitness in patients with Pulmonary arterial hypertension(PAH).
Status | Completed |
Enrollment | 30 |
Est. completion date | December 28, 2019 |
Est. primary completion date | November 29, 2019 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 45 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Patients who were clinically stable and compensated under optimized medical therapy - World health organization (WHO) Classification of functional class II to III PAH - Patients with ejection fraction = 40% - Non-smokers - body mass index = 35 kg/m2 Exclusion Criteria: - Any patient with respiratory failure - unstable angina - renal, hepatic or neuromuscular disorders - history of syncopal attacks - uncontrolled systemic hypertension - peripheral vascular disease - serious cardiac dysrhythmias on resting ECG - evidence of severe COPD at pulmonary function testing, - any known musculoskeletal or neurological conditions that might interfere with the execution or the assessment of the exercise |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Physical Therapy | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pulmonary artery systolic pressure (PASP) | Pulsed Doppler Echocardiogram for assessing PASP as calculated from the gradient across the tricuspid valve using the modified Bernoulli equation. | change from baseline at 12 weeks | |
Primary | Subjective self-report questionnaire that assesses sleep quality | The Pittsburgh Sleep Quality Index is a subjective self-report questionnaire that assesses sleep quality over a 1-month time interval in different populations It is 5 points score (0 means normal, 5 means severe sleep disturbance) | change from baseline at 12 weeks | |
Primary | Determining sleep patterns | Determining sleep patterns by using actigraph to assess suspected certain sleep disorders, | change from baseline at 12 weeks | |
Primary | Measuring aerobic fitness | Level of aerobic fitness assessed by using Cardiopulmonary exercise testing (CPET) through incremental exercise intensity until voluntary exhaustion. | change from baseline at 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05056532 -
Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension
|
||
Active, not recruiting |
NCT06003244 -
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)
|
N/A | |
Active, not recruiting |
NCT06072417 -
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
|
N/A | |
Recruiting |
NCT02966665 -
: Vascular Function in Health and Disease
|
Phase 1 | |
Recruiting |
NCT00502398 -
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
|
N/A | |
Completed |
NCT04456998 -
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
|
Phase 2 | |
Not yet recruiting |
NCT06035861 -
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
|
N/A | |
Recruiting |
NCT03138863 -
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
|
N/A | |
Recruiting |
NCT02102672 -
Trimetazidine in Pulmonary Artery Hypertension
|
Phase 2 | |
Withdrawn |
NCT06122922 -
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)
|
Phase 2 | |
Recruiting |
NCT03195543 -
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
|
||
Completed |
NCT03198910 -
Retrospective Data Analysis of Data From the Zurich PH Registry
|
||
Completed |
NCT03979482 -
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
|
||
Active, not recruiting |
NCT05996302 -
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)
|
N/A | |
Active, not recruiting |
NCT06084559 -
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
|
N/A | |
Withdrawn |
NCT02684786 -
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
|
Phase 1 | |
Not yet recruiting |
NCT06258850 -
REstoration of VItamin D in Pulmonary Arterial Hypertension
|
Phase 4 | |
Completed |
NCT04094272 -
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection
|
||
Active, not recruiting |
NCT01763112 -
Training With Whole Body Vibration Device in Patients With PAH
|
N/A | |
Completed |
NCT01581086 -
Vascular Subphenotypes of Lung Disease in HIV & COPD
|
N/A |